by Indication (Influenza, Rotavirus, DTP, COVID-19), Route of Administration (Intramuscular, Subcutaneous, Oral), Type/Antigen (Conjugate Vaccines, Live Attenuated Vaccines), and Valence (Multivalent, Monovalent Vaccines) Forecast to 2027 , published by Meticulous Research
®, the vaccines market is expected to grow at a CAGR of 12.5% from 2020 to 2027 to reach $108.02 billion by 2027.
The high prevalence of diseases, increasing government initiatives towards immunization, technological advancements in vaccine production, the strong pipeline for vaccines globally, and the emergence of the COVID-19 pandemic are the key factors expected to propel the growth of the vaccines market. Besides, the increasing epidemic potential, growing focus on therapeutic vaccines, and emerging markets are expected to offer significant growth opportunities for players operating in the vaccines market.
Germany
Australia
Japan
United-states
India
United-kingdom
Canada
France
London
City-of
Britain
America